Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18 USD | -1.04% | +3.81% | -33.46% |
04-29 | Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating | MT |
04-22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Evolution of the average Target Price on Guardant Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Guardant Health, Inc.
Canaccord Genuity | |
Goldman Sachs | |
Piper Sandler | |
UBS | |
Raymond James | |
Morgan Stanley | |
BofA Securities | |
Bernstein | |
Citigroup | |
Credit Suisse | |
Scotiabank | |
Cowen | |
BTIG | |
JPMorgan Chase | |
Stephens Inc. | |
Craig-Hallum | |
SVB Leerink | |
Stifel Nicolaus | |
Wells Fargo Securities |
EPS Revisions
- Stock Market
- Equities
- GH Stock
- Consensus Guardant Health, Inc.